Global Nasal Drug Delivery Technology Market size is expected to grow at a CAGR of 6.9% throughout the forecast period, reaching nearly US$ 93.69 Bn. by 2029.Nasal Drug Delivery Market Definition
The rising incidence of chronic diseases is also projected to contribute to marketplace expansion over the coming years. The non-pressurized packing containers segment is likely to grow at a CAGR of xx% during the estimated period. North America is probable to dominate the global nasal drug delivery market during the forecast duration. Moreover, the well-developed healthcare region and the presence of a big variety of medical device companies in this region increase marketplace growth. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report
Nasal Drug Delivery Market Dynamics
The use of the nasal route for the delivery of hard drugs inclusive of small polar molecules, vaccines, hormones, peptides, and proteins has created tons hobby in recent times. Owing to the excessive permeability, high vasculature, the low enzymatic environment of the nasal cavity and avoidance of hepatic first pass metabolism are properly suitable for systemic shipping of drug molecule through the nostril. Many drug delivery devices for nasal utility of liquid, semisolid and stable formulation are investigated to deliver the drugs to the treatment of most crisis CNS illnesses (i.e., Parkinson’s disease, Alzheimer’s disorder) because it requires speedy and/or specific focused on of drugs to the mind. The developing incidence of chronic diseases is also anticipated to contribute to marketplace expansion over the coming years. Rising patient preference for nasal drug delivery as a result of easy management & higher efficiency and developing adoption of self-administration practices are a number of the primary factors driving the growth of the nasal drug delivery technology market. Besides, growth amongst over the counter nasal drugs and growing attention on alternative routes of drug transport together with nasal drug delivery provide sizable boom possibilities for players working within the marketplace. Intranasal drug transport is one of the most desired drugs this will majorly be attributed to the non-invasive nature of this route of delivery and the reality that drug absorbability is higher through the nasal route. Delivery routes between patients in addition to healthcare carriers. In addition, the nasal path gives less antagonistic surroundings in comparison to the gastro-intestinal course; this permits higher absorption of drugs. Considering those factors, the inclination for nasal drug delivery is growing amongst patients in addition to healthcare carriers. Furthermore, the commercialization of novel products and the presence of strong product pipeline are expected to reinforce the marketplace growth. For instance, Eli Lilly and Company developed a healing spray (intranasal glucagon) for the remedy of low blood sugar. According to the Global Asthma Report 2018, published via Global Asthma Network, around 330 million people suffer from asthma. Moreover, nasal drug delivery systems offer benefits, inclusive of noninvasiveness and reduction in lag-time precipitated due to oral drug delivery. These advantages help in providing better patient comfort, which in turn, improves their adherence to medicine. According to a study led via Binghamton University, State University at New York, in August 2018, Narcan (naloxone), a single-step nasal spray, is the very best product to deliver. However, complications associated with the overuse of nasal sprays may additionally restraint the growth of the market.Nasal Drug Delivery Market Segment analysis
Based on the container, the non-pressurized packing containers segment is projected to grow at a CAGR of xx% during the forecast length. The nasal drug delivery generation marketplace is segmented into pressurized and non-pressurized packing containers. In 2022, the non-pressurized containers segment is anticipated to account for the most important percentage of the marketplace. This may be in most cases attributed to advantages which include higher versatility and reliability, immediate accessibility, self-containment, better portability, and coffee-value scientific aerosol delivery. Furthermore, the growing utilization of those devices for the remedy of reversible airflow obstruction as a result of allergies and chronic obstructive pulmonary disease (COPD) is predicted to further pressure the growth of this marketplace within the coming years. COPD was the fourth-leading trusted source cause of death in the United States in 2017, following heart disease, cancer, and unintentional injuries.Regional analysis
North America is likely to lead the global nasal drug delivery market during the forecast duration. Additionally, the well-developed healthcare region and the presence of a big variety of medical device companies in this region increase marketplace growth. According to the Centers for Disease Control and Prevention in January 2017, 30.8 million adults have been diagnosed with sinusitis in the US. As the continual obstructive pulmonary disease is determined to be the third leading reason for demise in the United States, therefore the growing occurrence of COPD may additionally help in growing the acceptance of nasal drug delivery devices. There is likewise increasingly a person with bronchial asthma that helps to see robust growth over the forecast length. In 2018, in step with a observe published in the U.S. National Library of Medicine National Institutes of Health, the occurrence of bronchial asthma is continuously excessive in Korea, in particular among women and aged populations.Nasal Drug Delivery Market Key Development
In April 17, 2022– 3M has announced that it is manufacturing an authorized generic of PROVENTIL® HFA (albuterol sulfate) Inhalation Aerosol in the U.S., which will be distributed by Par Pharmaceutical (Par) an operating company of Endo International plc. The objective of the report is to present a comprehensive analysis of the Global Nasal Drug Delivery Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Nasal Drug Delivery Market dynamics, structure by analysing the market segments and projects the Global Nasal Drug Delivery Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Nasal Drug Delivery Market make the report investor’s guide.Scope of the Nasal Drug Delivery Market: Inquire before buying
Nasal Drug Delivery Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 58.72 Bn. Forecast Period 2023 to 2029 CAGR: 6.9% Market Size in 2029: US $ 93.69 Bn. Segments Covered: by Dosage Form Sprays Drops & Liquids Powders Gels by Container Pressurized Containers Non-pressurized Containers by Application Allergic and Non-allergic Rhinitis Nose Congestion Vaccination Other Therapeutic Applications Nasal Drug Delivery Market, by Regions
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)Key Players are:
1.3M 2.Neurelis, Inc. 3.Aptargroup, Inc. 4.Astrazeneca PC 5.Becton, Dickinson and Company 6.Glaxosmithkline PLC 7.Johnson & Johnson Services, Inc. 8.Merck & Co., Inc. 9.Novartis AG 10.Pfizer Inc. 11.Mystic Pharmaceuticals 12.Bausch Health 13.OptiNose US 14.Dr. Reddy’s Laboratories Ltd. 15.Flo Nasal Products 16.Cadila Pharmaceuticals 17.PendoPharm Inc. Frequently Asked questions 1. What is the market size of the Global Nasal Drug Delivery Technology Market in 2022? Ans. The market size Global Nasal Drug Delivery Technology Market in 2022 was US$ 58.72 Billion. 2. What are the different segments of the Global Nasal Drug Delivery Technology Market? Ans. The Global Nasal Drug Delivery Technology Market is divided into Product, Application and Distribution Channel. 3. What is the study period of this market? Ans. The Global Nasal Drug Delivery Technology Market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global Nasal Drug Delivery Technology Market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Nasal Drug Delivery Technology Market? Ans. The Forecast Period of the market is 2023-2029 in the market.
Global Nasal Drug Delivery Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Tracheostomy Tubes Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Nasal Drug Delivery Market Analysis and Forecast 6.1. Global Nasal Drug Delivery Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Nasal Drug Delivery Market Analysis and Forecast, By Dosage Form 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Nasal Drug Delivery Market Value Share Analysis, By Dosage Form 7.4. Global Nasal Drug Delivery Market Size (US$ Bn) Forecast, By Dosage Form 7.5. Global Nasal Drug Delivery Market Analysis, By Dosage Form 7.6. Global Nasal Drug Delivery Market Attractiveness Analysis, By Dosage Form 8. Global Nasal Drug Delivery Market Analysis and Forecast, By Container 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Nasal Drug Delivery Market Value Share Analysis, By Container 8.4. Global Nasal Drug Delivery Market Size (US$ Bn) Forecast, By Container 8.5. Global Nasal Drug Delivery Market Analysis, By Container 8.6. Global Nasal Drug Delivery Market Attractiveness Analysis, By Container 9. Global Nasal Drug Delivery Market Analysis and Forecast, By Therapeutic Application 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Nasal Drug Delivery Market Value Share Analysis, By Therapeutic Application 9.4. Global Nasal Drug Delivery Market Size (US$ Bn) Forecast, By Therapeutic Application 9.5. Global Nasal Drug Delivery Market Analysis, By Therapeutic Application 9.6. Global Nasal Drug Delivery Market Attractiveness Analysis, By Therapeutic Application 10. Global Nasal Drug Delivery Market Analysis, by Region 10.1. Global Nasal Drug Delivery Market Value Share Analysis, by Region 10.2. Global Nasal Drug Delivery Market Size (US$ Bn) Forecast, by Region 10.3. Global Nasal Drug Delivery Market Attractiveness Analysis, by Region 11. North America Nasal Drug Delivery Market Analysis 11.1. Key Findings 11.2. North America Nasal Drug Delivery Market Overview 11.3. North America Nasal Drug Delivery Market Value Share Analysis, By Dosage Form 11.4. North America Nasal Drug Delivery Market Forecast, By Dosage Form 11.4.1. Sprays 11.4.2. Drops & Liquids 11.4.3. Powders 11.4.4. Gels 11.5. North America Nasal Drug Delivery Market Value Share Analysis, By Container 11.6. North America Nasal Drug Delivery Market Forecast, By Container 11.6.1. Pressurized Containers 11.6.2. Non-pressurized Containers 11.7. North America Nasal Drug Delivery Market Value Share Analysis, By Therapeutic Application 11.8. North America Nasal Drug Delivery Market Forecast, By Therapeutic Application 11.8.1. Allergic and Non-allergic Rhinitis 11.8.2. Nose Congestion 11.8.3. Vaccination 11.8.4. Other Therapeutic Applications 11.9. North America Nasal Drug Delivery Market Value Share Analysis, by Country 11.10. North America Nasal Drug Delivery Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Nasal Drug Delivery Market Analysis, by Country 11.12. U.S. Nasal Drug Delivery Market Forecast, By Dosage Form 11.12.1. Sprays 11.12.2. Drops & Liquids 11.12.3. Powders 11.12.4. Gels 11.13. U.S. Nasal Drug Delivery Market Forecast, By Container 11.13.1. Pressurized Containers 11.13.2. Non-pressurized Containers 11.14. U.S. Nasal Drug Delivery Market Forecast, By Therapeutic Application 11.14.1. Allergic and Non-allergic Rhinitis 11.14.2. Nose Congestion 11.14.3. Vaccination 11.14.4. Other Therapeutic Applications 11.15. Canada Nasal Drug Delivery Market Forecast, By Dosage Form 11.15.1. Sprays 11.15.2. Drops & Liquids 11.15.3. Powders 11.15.4. Gels 11.16. Canada Nasal Drug Delivery Market Forecast, By Container 11.16.1. Pressurized Containers 11.16.2. Non-pressurized Containers 11.17. Canada Nasal Drug Delivery Market Forecast, By Therapeutic Application 11.17.1. Allergic and Non-allergic Rhinitis 11.17.2. Nose Congestion 11.17.3. Vaccination 11.17.4. Other Therapeutic Applications 11.18. North America Nasal Drug Delivery Market Attractiveness Analysis 11.18.1. By Dosage Form 11.18.2. By Container 11.18.3. By Therapeutic Application 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Nasal Drug Delivery Market Analysis 12.1. Key Findings 12.2. Europe Nasal Drug Delivery Market Overview 12.3. Europe Nasal Drug Delivery Market Value Share Analysis, By Dosage Form 12.4. Europe Nasal Drug Delivery Market Forecast, By Dosage Form 12.4.1. Sprays 12.4.2. Drops & Liquids 12.4.3. Powders 12.4.4. Gels 12.5. Europe Nasal Drug Delivery Market Value Share Analysis, By Container 12.6. Europe Nasal Drug Delivery Market Forecast, By Container 12.6.1. Pressurized Containers 12.6.2. Non-pressurized Containers 12.7. Europe Nasal Drug Delivery Market Value Share Analysis, By Therapeutic Application 12.8. Europe Nasal Drug Delivery Market Forecast, By Therapeutic Application 12.8.1. Allergic and Non-allergic Rhinitis 12.8.2. Nose Congestion 12.8.3. Vaccination 12.8.4. Other Therapeutic Applications 12.9. Europe Nasal Drug Delivery Market Value Share Analysis, by Country 12.10. Europe Nasal Drug Delivery Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Nasal Drug Delivery Market Analysis, by Country 12.12. Germany Nasal Drug Delivery Market Forecast, By Dosage Form 12.12.1. Sprays 12.12.2. Drops & Liquids 12.12.3. Powders 12.12.4. Gels 12.13. Germany Nasal Drug Delivery Market Forecast, By Container 12.13.1. Pressurized Containers 12.13.2. Non-pressurized Containers 12.14. Germany Nasal Drug Delivery Market Forecast, By Therapeutic Application 12.14.1. Allergic and Non-allergic Rhinitis 12.14.2. Nose Congestion 12.14.3. Vaccination 12.14.4. Other Therapeutic Applications 12.15. U.K. Nasal Drug Delivery Market Forecast, By Dosage Form 12.15.1. Sprays 12.15.2. Drops & Liquids 12.15.3. Powders 12.15.4. Gels 12.16. U.K. Nasal Drug Delivery Market Forecast, By Container 12.16.1. Pressurized Containers 12.16.2. Non-pressurized Containers 12.17. U.K. Nasal Drug Delivery Market Forecast, By Therapeutic Application 12.17.1. Allergic and Non-allergic Rhinitis 12.17.2. Nose Congestion 12.17.3. Vaccination 12.17.4. Other Therapeutic Applications 12.18. France Nasal Drug Delivery Market Forecast, By Dosage Form 12.18.1. Sprays 12.18.2. Drops & Liquids 12.18.3. Powders 12.18.4. Gels 12.19. France Nasal Drug Delivery Market Forecast, By Container 12.19.1. Pressurized Containers 12.19.2. Non-pressurized Containers 12.20. France Nasal Drug Delivery Market Forecast, By Therapeutic Application 12.20.1. Allergic and Non-allergic Rhinitis 12.20.2. Nose Congestion 12.20.3. Vaccination 12.20.4. Other Therapeutic Applications 12.21. Italy Nasal Drug Delivery Market Forecast, By Dosage Form 12.21.1. Sprays 12.21.2. Drops & Liquids 12.21.3. Powders 12.21.4. Gels 12.22. Italy Nasal Drug Delivery Market Forecast, By Container 12.22.1. Pressurized Containers 12.22.2. Non-pressurized Containers 12.23. Italy Nasal Drug Delivery Market Forecast, By Therapeutic Application 12.23.1. Allergic and Non-allergic Rhinitis 12.23.2. Nose Congestion 12.23.3. Vaccination 12.23.4. Other Therapeutic Applications 12.24. Spain Nasal Drug Delivery Market Forecast, By Dosage Form 12.24.1. Sprays 12.24.2. Drops & Liquids 12.24.3. Powders 12.24.4. Gels 12.25. Spain Nasal Drug Delivery Market Forecast, By Container 12.25.1. Pressurized Containers 12.25.2. Non-pressurized Containers 12.26. Spain Nasal Drug Delivery Market Forecast, By Therapeutic Application 12.26.1. Allergic and Non-allergic Rhinitis 12.26.2. Nose Congestion 12.26.3. Vaccination 12.26.4. Other Therapeutic Applications 12.27. Rest of Europe Nasal Drug Delivery Market Forecast, By Dosage Form 12.27.1. Sprays 12.27.2. Drops & Liquids 12.27.3. Powders 12.27.4. Gels 12.28. Rest of Europe Nasal Drug Delivery Market Forecast, By Container 12.28.1. Pressurized Containers 12.28.2. Non-pressurized Containers 12.29. Rest Of Europe Nasal Drug Delivery Market Forecast, By Therapeutic Application 12.29.1. Allergic and Non-allergic Rhinitis 12.29.2. Nose Congestion 12.29.3. Vaccination 12.29.4. Other Therapeutic Applications 12.30. Europe Nasal Drug Delivery Market Attractiveness Analysis 12.30.1. By Dosage Form 12.30.2. By Container 12.30.3. By Therapeutic Application 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Nasal Drug Delivery Market Analysis 13.1. Key Findings 13.2. Asia Pacific Nasal Drug Delivery Market Overview 13.3. Asia Pacific Nasal Drug Delivery Market Value Share Analysis, By Dosage Form 13.4. Asia Pacific Nasal Drug Delivery Market Forecast, By Dosage Form 13.4.1. Sprays 13.4.2. Drops & Liquids 13.4.3. Powders 13.4.4. Gels 13.5. Asia Pacific Nasal Drug Delivery Market Value Share Analysis, By Container 13.6. Asia Pacific Nasal Drug Delivery Market Forecast, By Container 13.6.1. Pressurized Containers 13.6.2. Non-pressurized Containers 13.7. Asia Pacific Nasal Drug Delivery Market Value Share Analysis, By Therapeutic Application 13.8. Asia Pacific Nasal Drug Delivery Market Forecast, By Therapeutic Application 13.8.1. Allergic and Non-allergic Rhinitis 13.8.2. Nose Congestion 13.8.3. Vaccination 13.8.4. Other Therapeutic Applications 13.9. Asia Pacific Nasal Drug Delivery Market Value Share Analysis, by Country 13.10. Asia Pacific Nasal Drug Delivery Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Nasal Drug Delivery Market Analysis, by Country 13.12. China Nasal Drug Delivery Market Forecast, By Dosage Form 13.12.1. Sprays 13.12.2. Drops & Liquids 13.12.3. Powders 13.12.4. Gels 13.13. China Nasal Drug Delivery Market Forecast, By Container 13.13.1. Pressurized Containers 13.13.2. Non-pressurized Containers 13.14. China Nasal Drug Delivery Market Forecast, By Therapeutic Application 13.14.1. Allergic and Non-allergic Rhinitis 13.14.2. Nose Congestion 13.14.3. Vaccination 13.14.4. Other Therapeutic Applications 13.15. India Nasal Drug Delivery Market Forecast, By Dosage Form 13.15.1. Sprays 13.15.2. Drops & Liquids 13.15.3. Powders 13.15.4. Gels 13.16. India Nasal Drug Delivery Market Forecast, By Container 13.16.1. Pressurized Containers 13.16.2. Non-pressurized Containers 13.17. India Nasal Drug Delivery Market Forecast, By Therapeutic Application 13.17.1. Allergic and Non-allergic Rhinitis 13.17.2. Nose Congestion 13.17.3. Vaccination 13.17.4. Other Therapeutic Applications 13.18. Japan Nasal Drug Delivery Market Forecast, By Dosage Form 13.18.1. Sprays 13.18.2. Drops & Liquids 13.18.3. Powders 13.18.4. Gels 13.19. Japan Nasal Drug Delivery Market Forecast, By Container 13.19.1. Pressurized Containers 13.19.2. Non-pressurized Containers 13.20. Japan Nasal Drug Delivery Market Forecast, By Therapeutic Application 13.20.1. Allergic and Non-allergic Rhinitis 13.20.2. Nose Congestion 13.20.3. Vaccination 13.20.4. Other Therapeutic Applications 13.21. ASEAN Nasal Drug Delivery Market Forecast, By Dosage Form 13.21.1. Sprays 13.21.2. Drops & Liquids 13.21.3. Powders 13.21.4. Gels 13.22. ASEAN Nasal Drug Delivery Market Forecast, By Container 13.22.1. Pressurized Containers 13.22.2. Non-pressurized Containers 13.23. ASEAN Nasal Drug Delivery Market Forecast, By Therapeutic Application 13.23.1. Allergic and Non-allergic Rhinitis 13.23.2. Nose Congestion 13.23.3. Vaccination 13.23.4. Other Therapeutic Applications 13.24. Rest of Asia Pacific Nasal Drug Delivery Market Forecast, By Dosage Form 13.24.1. Sprays 13.24.2. Drops & Liquids 13.24.3. Powders 13.24.4. Gels 13.25. Rest of Asia Pacific Nasal Drug Delivery Market Forecast, By Container 13.25.1. Pressurized Containers 13.25.2. Non-pressurized Containers 13.26. Rest of Asia Pacific Nasal Drug Delivery Market Forecast, By Therapeutic Application 13.26.1. Allergic and Non-allergic Rhinitis 13.26.2. Nose Congestion 13.26.3. Vaccination 13.26.4. Other Therapeutic Applications 13.27. Asia Pacific Nasal Drug Delivery Market Attractiveness Analysis 13.27.1. By Dosage Form 13.27.2. By Container 13.27.3. By Therapeutic Application 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Nasal Drug Delivery Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Nasal Drug Delivery Market Overview 14.3. Middle East & Africa Nasal Drug Delivery Market Value Share Analysis, By Dosage Form 14.4. Middle East & Africa Nasal Drug Delivery Market Forecast, By Dosage Form 14.4.1. Sprays 14.4.2. Drops & Liquids 14.4.3. Powders 14.4.4. Gels 14.5. Middle East & Africa Nasal Drug Delivery Market Value Share Analysis, By Container 14.6. Middle East & Africa Nasal Drug Delivery Market Forecast, By Container 14.6.1. Pressurized Containers 14.6.2. Non-pressurized Containers 14.7. Middle East & Africa Nasal Drug Delivery Market Value Share Analysis, By Therapeutic Application 14.8. Middle East & Africa Nasal Drug Delivery Market Forecast, By Therapeutic Application 14.8.1. Allergic and Non-allergic Rhinitis 14.8.2. Nose Congestion 14.8.3. Vaccination 14.8.4. Other Therapeutic Applications 14.9. Middle East & Africa Nasal Drug Delivery Market Value Share Analysis, by Country 14.10. Middle East & Africa Nasal Drug Delivery Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Nasal Drug Delivery Market Analysis, by Country 14.12. GCC Nasal Drug Delivery Market Forecast, By Dosage Form 14.12.1. Sprays 14.12.2. Drops & Liquids 14.12.3. Powders 14.12.4. Gels 14.13. GCC Nasal Drug Delivery Market Forecast, By Container 14.13.1. Pressurized Containers 14.13.2. Non-pressurized Containers 14.14. GCC Nasal Drug Delivery Market Forecast, By Therapeutic Application 14.14.1. Allergic and Non-allergic Rhinitis 14.14.2. Nose Congestion 14.14.3. Vaccination 14.14.4. Other Therapeutic Applications 14.15. South Africa Nasal Drug Delivery Market Forecast, By Dosage Form 14.15.1. Sprays 14.15.2. Drops & Liquids 14.15.3. Powders 14.15.4. Gels 14.16. South Africa Nasal Drug Delivery Market Forecast, By Container 14.16.1. Pressurized Containers 14.16.2. Non-pressurized Containers 14.17. South Africa Nasal Drug Delivery Market Forecast, By Therapeutic Application 14.17.1. Allergic and Non-allergic Rhinitis 14.17.2. Nose Congestion 14.17.3. Vaccination 14.17.4. Other Therapeutic Applications 14.18. Rest of Middle East & Africa Nasal Drug Delivery Market Forecast, By Dosage Form 14.18.1. Sprays 14.18.2. Drops & Liquids 14.18.3. Powders 14.18.4. Gels 14.19. Rest of Middle East & Africa Nasal Drug Delivery Market Forecast, By Container 14.19.1. Pressurized Containers 14.19.2. Non-pressurized Containers 14.20. Rest of Middle East & Africa Nasal Drug Delivery Market Forecast, By Therapeutic Application 14.20.1. Allergic and Non-allergic Rhinitis 14.20.2. Nose Congestion 14.20.3. Vaccination 14.20.4. Other Therapeutic Applications 14.21. Middle East & Africa Nasal Drug Delivery Market Attractiveness Analysis 14.21.1. By Dosage Form 14.21.2. By Container 14.21.3. By Therapeutic Application 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Nasal Drug Delivery Market Analysis 15.1. Key Findings 15.2. South America Nasal Drug Delivery Market Overview 15.3. South America Nasal Drug Delivery Market Value Share Analysis, By Dosage Form 15.4. South America Nasal Drug Delivery Market Forecast, By Dosage Form 15.4.1. Sprays 15.4.2. Drops & Liquids 15.4.3. Powders 15.4.4. Gels 15.5. South America Nasal Drug Delivery Market Value Share Analysis, By Container 15.6. South America Nasal Drug Delivery Market Forecast, By Container 15.6.1. Pressurized Containers 15.6.2. Non-pressurized Containers 15.7. South America Nasal Drug Delivery Market Value Share Analysis, By Therapeutic Application 15.8. South America Nasal Drug Delivery Market Forecast, By Therapeutic Application 15.8.1. Allergic and Non-allergic Rhinitis 15.8.2. Nose Congestion 15.8.3. Vaccination 15.8.4. Other Therapeutic Applications 15.9. South America Nasal Drug Delivery Market Value Share Analysis, by Country 15.10. South America Nasal Drug Delivery Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Nasal Drug Delivery Market Analysis, by Country 15.12. Brazil Nasal Drug Delivery Market Forecast, By Dosage Form 15.12.1. Sprays 15.12.2. Drops & Liquids 15.12.3. Powders 15.12.4. Gels 15.13. Brazil Nasal Drug Delivery Market Forecast, By Container 15.13.1. Pressurized Containers 15.13.2. Non-pressurized Containers 15.14. Brazil Nasal Drug Delivery Market Forecast, By Therapeutic Application 15.14.1. Allergic and Non-allergic Rhinitis 15.14.2. Nose Congestion 15.14.3. Vaccination 15.14.4. Other Therapeutic Applications 15.15. Mexico Nasal Drug Delivery Market Forecast, By Dosage Form 15.15.1. Sprays 15.15.2. Drops & Liquids 15.15.3. Powders 15.15.4. Gels 15.16. Mexico Nasal Drug Delivery Market Forecast, By Container 15.16.1. Pressurized Containers 15.16.2. Non-pressurized Containers 15.17. Mexico Nasal Drug Delivery Market Forecast, By Therapeutic Application 15.17.1. Allergic and Non-allergic Rhinitis 15.17.2. Nose Congestion 15.17.3. Vaccination 15.17.4. Other Therapeutic Applications 15.18. Rest of South America Nasal Drug Delivery Market Forecast, By Dosage Form 15.18.1. Sprays 15.18.2. Drops & Liquids 15.18.3. Powders 15.18.4. Gels 15.19. Rest of South America Nasal Drug Delivery Market Forecast, By Container 15.19.1. Pressurized Containers 15.19.2. Non-pressurized Containers 15.20. Rest of South America Nasal Drug Delivery Market Forecast, By Therapeutic Application 15.20.1. Allergic and Non-allergic Rhinitis 15.20.2. Nose Congestion 15.20.3. Vaccination 15.20.4. Other Therapeutic Applications 15.21. South America Nasal Drug Delivery Market Attractiveness Analysis 15.21.1. By Dosage Form 15.21.2. By Container 15.21.3. By Therapeutic Application 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. 3M 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Neurelis, Inc. 16.3.3. Aptargroup, Inc. 16.3.4. Astrazeneca PC 16.3.5. Becton, Dickinson and Company 16.3.6. Glaxosmithkline PLC 16.3.7. Johnson & Johnson Services, Inc. 16.3.8. Merck & Co., Inc. 16.3.9. Novartis AG 16.3.10. Pfizer Inc. 16.3.11. Mystic Pharmaceuticals 16.3.12. Bausch Health 16.3.13. OptiNose US 16.3.14. Dr. Reddy’s Laboratories Ltd. 16.3.15. Flo Nasal Products 16.3.16. Cadila Pharmaceuticals 16.3.17. PendoPharm Inc. 16.4. Primary Key Insights